SCHEMBL1491018

SCHEMBL1491018

[CH2]CC(NS(C)(=O)=O)c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
ALDH1A1 P00352 3/20 0.40
KCNA5 P22460 3/20 0.39
KCNE1 P15382 1/20 0.39
KCNQ1 P51787 1/20 0.39
KCND3 Q9UK17 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CFTR P13569 2/20 0.39
GOPC Q9HD26 2/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
MAPK1 P28482 2/20 0.38
KCNH2 Q12809 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490877 0.73 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HTT
SCHEMBL1490865 0.72 CYP2A6 (0.31)
SCHEMBL1486713 0.71 ADAMTS4 (0.40) ALDH1A1MEN1KMT2A
SCHEMBL27074457 0.70 SLC6A2 (0.42) L3MBTL1LMNASMN1; SMN2KDM4ECFTR
SCHEMBL27425068 0.70 NAPRT (0.44) KCNA5L3MBTL1LMNASMN1; SMN2KDM4E
SCHEMBL27608986 0.70 SUCNR1 (0.53) LMNAMAPK1
SCHEMBL7878877 0.69 CFTR (0.57) KCNA5L3MBTL1LMNASMN1; SMN2KDM4E
SCHEMBL27703681 0.68 CFTR (0.50) ALDH1A1KCNA5L3MBTL1LMNASMN1; SMN2
SCHEMBL9046110 0.67 CFTR (0.46) KCNA5L3MBTL1LMNASMN1; SMN2KDM4E
SCHEMBL7416466 0.67 CFTR (0.46) ALDH1A1KCNA5L3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897609-B2 Aryl substituted imidazonaphthyridines 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-03-01 US disclosed